Vicarious Surgical to Liquidate After Shareholder Approval
Vicarious Surgical, a surgical robot developer that raised over $425 million from investors including Bill Gates, is shutting down after shareholders voted to wind down and liquidate the business. The company, which went public via a SPAC merger in 2021 at a $1.1 billion valuation, failed to achieve FDA regulatory authorization for its single-port surgical robot. Despite receiving breakthrough device designation from the FDA, the company faced repeated delays, canceled clinical trial plans, and burned through cash. New CEO Stephen From, appointed less than a year ago, outsourced design aspects to save money but could not secure additional funding or a buyer. The company employed 26 people as of March 2026 and plans to file for dissolution in Delaware.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page itself is projected from evidence records.
- Current automated evidence projection